Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli
- Authors:
View Affiliations
Affiliations: Department of Respiration, Xuzhou City Hospital Affiliated to Xuzhou Medical College, Xuzhou, Jiangsu, P.R. China, Department of Respiration, Jining No.1 People's Hospital, Jining, Shandong, P.R. China
- Published online on: April 21, 2016 https://doi.org/10.3892/br.2016.661
-
Pages:
687-690
-
Copyright: © Liu
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Escherichia coli (E. coli) is a common opportunistic pathogen for nosocomial infection. The aim of the study was to examine the phenotype, genotype and epidemiology of plasmid‑mediated AmpC β‑lactamases in E. coli. In total, 96 clinical isolates of repeated E. coli were collected from different hospitals between August and October 2012. Using a cefoxitin disk diffusion method to identify the phenotype of AmpC β‑lactamases in E. coli, the plasmid was extracted, and multiplex polymerase chain reaction (PCR) was used to determine the amp gene. The PCR products were purified and sequenced. Of the 96 isolates strains, 43 strains were cefoxitin‑resistant. Twelve (12.5%) isolates were detected to produce AmpC β‑lactamases with multiplex PCR, 11 strains carried DHA type ampC‑resistant genes, and one strain carried ACC type ampC‑resistant genes. In conclusion, the incidence of producing a plasmid‑mediated AmpC enzyme of E. coli strains was relatively high. Therefore, antibiotics such as imipenem, a carbapenem, potentially serve as the treatment of choice for the infection.
View References
|
1
|
Weinstein RA: Nosocomial infection update.
Emerg Infect Dis. 4:416–420. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jacoby GA: AmpC beta-lactamases. Clin
Microbiol Rev. 22:161–182. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Markovska R, Schneider I, Marteva-Proevsk
Y, Mitov I, Bauernfeind A and Markova B: First detection of the
AmpC beta-lactamase ACC-1 in a Klebsiella pneumoniae isolate
in Bulgaria. J Chemother. 24:307–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma XZ, Lv Y and Xue F: Ministry of health,
the nationalantimicrobial resistance monitoring report: Bacterial
drug resistance monitoring bloodstream infection for 2010. Chin J
Nosocomiol. 21:5147–5151. 2011.(In Chinese).
|
|
5
|
Ahmed SF, Ali MM, Mohamed ZK, Moussa TA
and Klena JD: Fecal carriage of extended-spectrum beta-lactamases
and AmpC-producing Escherichia coli in a Libyan community.
Ann Clin Microbiol Antimicrob. 13:22.2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clinical and Laboratory Standards
Institute: Performance standards for antimicrobial susceptibility
testing. Sixteenth informational supplement. M100–S116. 2006.
|
|
7
|
Joseph NM and Mathias S: Challenges in
detection of AmpC β-lactamases among Enterobacteriaceae.
Indian J Med Res. 137:216–217. 2013.PubMed/NCBI
|
|
8
|
Yilmaz NO, Agus N, Bozcal E, Oner O and
Uzel A: Detection of plasmid-mediated AmpC β-lactamase in
Escherichia coli and Klebsiella pneumoniae. Indian J
Med Microbiol. 31:53–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong F, Xu X and Song W: Study on AmpC
beta lactamases in clinical isolates of Escherichia coli and
Klebsiella plasmid mediated. Chin Med J (Engl).
90:2723–2725. 2010.
|
|
10
|
Ying Ye, Qian Wang, Yan Chen and Jiabin
Li: Identification of plasmid-mediated AmpC β-lactamase in
Escherichia coli. Chin J Lab Med. 30:662–665. 2007.
|
